Nanotech

The X-factor required for bio-printed growth success

Bio-printed implants, optimised with growth factors, show promise in the repair of bone defects, tissue regeneration and vascularisation. A number of recent studies have demonstrated...

Cancer blood test maker Grail files for Nasdaq IPO

Grail is on a quest for early cancer detection; the company is going public after raising nearly $2b in funding for its development of...

Cutting surgical robots down to size

A new microsurgical robot shows promise in performing highly complex and delicate operations and can even outperform human surgeons. A new robot using an innovative...

Nanotech ‘passport to the brain’ for therapeutics

Researchers discover a new nanotech approach to deliver therapies through the blood-brain barrier. Scientists at Tufts University have discovered a way to deliver therapeutics safely...

Nanoparticles target immune response using red blood cells

Polystyrene nanoparticles deliver drug payload directly to the spleen and bypass lengthy clinical trial requirements. Vaccines are making headlines at the moment, for obvious reasons, ...

When scaling down is as vital as scaling up

Robotics continue to scale down - but can researchers include the autonomy necessary for the medical intervention that will prolong life? Tiny robots could be...

NaNotics raising Series B to support Asia-Pacific trials

NaNotics nano particles could revolutionise of a host of chronic and acute conditions. Louis Hawthorne, CEO of NaNotics, has released an 11 minute video aimed...

Hydrogel scaffold raises hopes for tissue regeneration

Wyss Institute hydrogel therapy can repair nerves, muscles and blood vessels. Naturally-occurring molecules VEGF and IGF-1 can enhance tissue regrowth and repair, but getting them...

‘Internet of the body’ device to regulate genes externally

Bioelectric remote control of cell signalling drives synthetic biology progress: tests trigger bioengineered cells to release insulin. A team at the Department of Biosystems Science and...

Novel approach breaks through blood-brain barrier

Molecular transport is on target for shuttling therapies directly into the brain. Like an exclusive nightclub, the brain has the best bouncer in the business....

Building an artificial immune system

DoD-funded ThirdLaw Technologies to harness the power of ‘spiroligomers’ to rapidly build new small molecules for Longevity therapies. Far from the world of stock market...

Longevity and the Singularity

Consciousness in the cloud? Where science fact and fiction collide. While the principle focus of Longevity is undoubtedly the extension of healthy human lifespan, there...

Longevity Leaders World Congress goes virtual

Annual Longevity conference gets a digital makeover as the community adapts to COVID-19. With much of the world still in some form of lockdown, the...

Making the Longevity grade: expanded list of 1000 leading names

2020 list showcases a growing network of Longevity influencers from the worlds of aging research, technology, policy, media and investment. Who's who in Longevity? Following-on...

Longevity and the art of motorcycle maintenance

OpenCures' Kevin Perrott talks about empowering the consumer with their own health data. One of the Longevity sector’s leading voices came to the field relatively...

Longevity2020: Day 3 recap

Experts, innovators, investors and the curious meet online in the biggest Longevity conference ever staged. As we enter the fourth day of Longevity2020, we thought...

Longevity 2020: shaping-up nicely

Over 45 confirmed speakers for this 5-day online event and a big thank you for your interest. We're moving fast! Longevity 2020 started just over...

Biological and artificial neurons linked using standard IP

A world wide web that is partly biological has been created around the globe by collaborating scientists. New nanoelectronic device research has enabled both artificial and...

Some good news: announcing Longevity2020

In these challenging times, with everyone working from home and conferences pushed-back to later this year, we had an idea: Longevity2020 While the world overcomes...

‘Damage-eating’ protein fixes DNA harmed by aging

A toolkit of proteins that can repair breaks in strands of DNA has been discovered by scientists at the Universities of Sheffield and Oxford. DNA...

Latest articles

Big Brother approach to accelerate preclinical studies

Tracked.bio develops AI computer vision system that tracks flies and mice to reduce man-hours and increase data collected in Longevity studies. A Danish start-up aims...

Deliver us from aging – the Quicksilver method

Bigger certainly doesn't mean better when it comes to Quicksilver's nutraceutical delivery methods. The COVID-19 pandemic has caused an upturn in the supplements industry; from...

Astellas to acquire iota Biosciences

Following an R&D collaboration that began last year, Japanese pharma Astellas has announced it will acquire bioelectronics firm iota in $304m deal. Last year's R&D...

OneSkin launches topical senetherapeutic skin treatment

Extending skinspan with non-invasive senetherapeutic proprietary peptide. OneSkin is a Longevity company on a mission to transform the way we think about skin. Today the...